...
首页> 外文期刊>The Internet Journal of Anesthesiology >Total Intravenous Anesthesia In Laparoscopic Cholecystectomy: Comparison Of Butorphanol And Fentanyl
【24h】

Total Intravenous Anesthesia In Laparoscopic Cholecystectomy: Comparison Of Butorphanol And Fentanyl

机译:腹腔镜胆囊切除术的全静脉麻醉:布托啡诺和芬太尼的比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The study aimed to compare the analgesic efficacy and recovery characteristics of fentanyl and butorphanol as analgesic under TIVA (Total Intravenous Anesthesia) for laparoscopic cholecystectomy and find out the better combination along with propofol. Materials and methods: Sixty patients of ASA grade I and II of either sex in the age group of 18-60 years undergoing laparoscopic cholecystectomy were allocated to one of the two groups of 30 each. Group I received inj. fentanyl in the doses of 2 μg/kg while patients in group II received butorphanol in doses of 25μg/kg. All the patients were induced with inj. propofol 2 μg/kg and intubated with 100 μg/kg Vecuronium. Anesthesia was maintained by oxygen and propofol. Intra-operative analgesic efficacy was measured by hemodynamic parameters (HR, MAP). Results and Conclusion: Suppression of sympathetic response to laryngoscopy and intubation was better with butorphanol than fentanyl. The emergence time, recovery time and post operative sedation was less in the fentanyl group (group I) while post operative analgesia was more in the butorphanol group (group II). There was no evidence of nausea and vomiting in any of the two groups. We can conclude that butorphanol provides better analgesia with total intravenous anesthesia as compared to fentanyl. Introduction Laparoscopic cholecystectomy combines the benefit of completely removing the gallbladder with the advantages of shorter hospital stays, more rapid return to normal activities, less pain associated with the small, limited incisions and less postoperative ileus compared with the open laparotomy technique. With the advancement in anesthesiology practice, the hospital stay has reduced. However, the basic requirements for anesthesia have not changed from “analgesia, anesthesia and muscle relaxation” (1).The availability of intravenous sedatives/hypnotics with rapid onset, stable operating conditions, shorter recovery profiles along with newer, more potent analgesics and user friendly infusion delivery systems has facilitated the TIVA technique to a great extent for laparoscopic procedures.Propofol has proven to be suitable as a hypnotic for TIVA technique providing rapid onset as well as rapid recovery of protective reflexes and of cognitive and psychomotor functions. At the same time, it must be administered in combination with drugs fulfilling other components of anesthesia.Out of all modalities available to relieve pain, systemic opioids stand atop. Opioids produce analgesia primarily as a result of their agonist effects on opioid receptors in the CNS. The physico-chemical properties of different opioids can result in difference in their pharmacokinetic, pharmacodynamic and side-effect profiles. Though, there are lots of studies including fentanyl as an adjuvant analgesic under TIVA technique, only very few studies have been done with butorphanol.Butorphanol, a synthetic opioid derivative is a mixed agonist-antagonist with analgesic potency greater than morphine and pethidine(2). Butorphanol and its metabolites are agonist at kappa-receptor (κ) and mixed agonist-antagonist at mu (μ) receptors. Butorphanol is available only in the parenteral form, thus better suited for acute pain relief. Butorphanol unlike morphine exhibits a ceiling effect on respiratory depression(3).The aims and objectives of this study were to compare the analgesic efficacy as well as recovery characteristics of intravenous butorphanol with intravenous fentanyl, as an adjuvant analgesic to TIVA for laparoscopic cholecystectomy. Material & Methods After obtaining approval from hospital ethical committee and informed consent from the patients, sixty patients between the age of 20-60 years belonging to ASA grade I and II scheduled for elective laparoscopic cholecystectomy were studied. The patients were subjected to detailed clinical examination and routine investigations to exclude any associated systemic disorder. Exclusion Criteria: The patients wit
机译:背景:该研究旨在比较芬太尼和丁烷酚在TIVA(全身静脉麻醉)下用于腹腔镜胆囊切除术的镇痛效果和恢复特性,并找出与丙泊酚一起使用的更好的组合。材料和方法:将年龄在18-60岁的年龄组的60例ASA I级和II级患者中,分别接受腹腔镜胆囊切除术,分为两组,每组30例。第一组收到注射。芬太尼的剂量为2μg/ kg,而第二组的患者则接受布托啡诺的剂量为25μg/ kg。所有患者均被注射。异丙酚2μg/ kg,并插管100μg/ kg维库溴铵。氧气和丙泊酚维持麻醉。术中镇痛效果通过血流动力学参数(HR,MAP)进行测量。结果与结论:丁苯啡诺比芬太尼对喉镜和插管的交感反应有更好的抑制作用。芬太尼组(I组)的出现时间,恢复时间和手术后镇静时间较少,而布托啡诺组(II组)的术后镇痛时间更长。两组均没有恶心和呕吐的迹象。我们可以得出结论,与芬太尼相比,丁苯啡诺在全静脉麻醉下具有更好的镇痛作用。简介与开放式剖腹术相比,腹腔镜胆囊切除术具有完全切除胆囊的优点,以及住院时间短,恢复正常活动更快,切口小,切口有限,术后肠梗阻少等优点。随着麻醉学实践的进步,住院时间减少了。但是,麻醉的基本要求并未从“镇痛,麻醉和肌肉松弛”改变(1)。静脉镇静剂/催眠药的出现,起效快,操作条件稳定,恢复期短以及新型,更有效的镇痛剂和使用者友好的输液输送系统极大地促进了TIVA技术在腹腔镜手术中的作用。异丙酚已被证明是TIVA技术的催眠药,可快速起效并迅速恢复保护性反射以及认知和精神运动功能。同时,它必须与具有麻醉作用的其他药物联用,在所有可减轻疼痛的方式中,全身性阿片类药物都位居首位。阿片类药物主要是由于它们对中枢神经系统中阿片受体的激动作用而产生镇痛作用。不同阿片类药物的理化性质可能导致它们的药代动力学,药效学和副作用概况不同。尽管在TIVA技术下有很多研究包括芬太尼作为辅助镇痛药,但对丁啡烷进行的研究很少,丁香酚是一种合成的阿片衍生物,是一种混合的激动剂-拮抗剂,具有比吗啡和哌替啶更大的镇痛作用(2)。 。 Butorphanol及其代谢物在Kappa受体(κ)上是激动剂,在mu(μ)受体上是混合的激动剂-拮抗剂。 Butorphanol仅以肠胃外形式提供,因此更适合急性疼痛缓解。与吗啡不同,布托啡诺对呼吸抑制的抑制作用最高(3)。本研究的目的和目的是比较静脉注射布托啡诺与静脉注射芬太尼的镇痛效果以及恢复特性,作为腹腔镜胆囊切除术的TIVA辅助镇痛剂。材料与方法在获得医院伦理委员会的批准并征得患者的知情同意后,研究了60名年龄在20至60岁之间的ASA I级和II级患者,这些患者计划进行择期腹腔镜胆囊切除术。对患者进行了详细的临床检查和常规检查,以排除任何相关的系统性疾病。排除标准:患者机智

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号